{
    "clinical_study": {
        "@rank": "72104", 
        "arm_group": [
            {
                "arm_group_label": "Electric Nebulizer", 
                "arm_group_type": "Active Comparator", 
                "description": "Pulmo-Aide Model 5650D"
            }, 
            {
                "arm_group_label": "Human-Powered Nebulizer", 
                "arm_group_type": "Experimental", 
                "description": "Human-Powered"
            }
        ], 
        "brief_summary": {
            "textblock": "This is an equivalence study comparing an electric nebulizer with a human-powered\n      nebulizer--one that does not need electricity--in the treatment of mild to moderate asthma\n      exacerbations in a regional clinic in San Salvador, El Salvador."
        }, 
        "brief_title": "Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "The study design is to treat individuals suffering from mild to moderate exacerbations of\n      asthma with nebulized salbutamol (2.5mg).  Subjects will receive nebulization using either\n      an electric nebulizer compressor or a human-powered nebulizer compressor.  Improvement in\n      peak expiratory flow will be the primary endpoint.  Blood oxygenation levels as measured by\n      pulse oximetry will be a secondary endpoint of the trial."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Suffering from Mild or Moderate Asthma symptoms\n\n          -  Increased respiratory rate, but not over 30 breaths per minute\n\n          -  Reduced peak expiratory flow rate, but not less than 60% of normal\n\n          -  Oxygen saturation levels reduced but greater than 90%\n\n        Exclusion Criteria:\n\n          -  Any other respiratory condition that would interfere with nebulizer treatment\n\n          -  If any other medication is being taken at the time\n\n          -  Pregnant women or women who may think they might be pregnant\n\n          -  Never taken salbutamol before"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795742", 
            "org_study_id": "MU-HR-2433"
        }, 
        "intervention": {
            "arm_group_label": [
                "Electric Nebulizer", 
                "Human-Powered Nebulizer"
            ], 
            "intervention_name": "Human-Powered Nebulizer", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Asthma", 
            "Nebulizers", 
            "Salbutamol", 
            "Developing Countries"
        ], 
        "lastchanged_date": "February 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ilopango", 
                    "country": "El Salvador", 
                    "state": "San Salvador"
                }, 
                "name": "Hospital Nacional San Bartolo"
            }
        }, 
        "location_countries": {
            "country": "El Salvador"
        }, 
        "number_of_arms": "2", 
        "official_title": "Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer in the Treatment of Mild to Moderate Asthma in El Salvador", 
        "overall_official": {
            "affiliation": "Marquette University", 
            "last_name": "Lars E Olson, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Improvement in Peak Expiratory Flow", 
            "safety_issue": "No", 
            "time_frame": "From before to after nebulizer treatment lasting approximately 30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795742"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Marquette University", 
            "investigator_full_name": "Lars Olson", 
            "investigator_title": "Associate Professor of Biomedical Engineering", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Improvement in blood oxygenation as measured by pulse oximetry", 
            "safety_issue": "No", 
            "time_frame": "From before to after nebulizer treatment lasting about 30 minutes"
        }, 
        "source": "Marquette University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Marquette University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}